Search Results - "Trashkov, A. P."

Evaluation of the genotoxic and antigenotoxic potential of lignin-derivative BP-C2 in the comet assay in vivo by Pigarev, S.E., Trashkov, A.P., Panchenko, A.V., Yurova, M.N., Bykov, V.N., Fedoros, E.I., Anisimov, V.N.

“…The genotoxic and antigenotoxic potential of BP-C2, a novel lignin-derived polyphenolic composition with ammonium molybdate, was investigated as a…”
Get full text

Current State and Development Trends of Regulative and Methodological Support of the Activities of Nuclear-Medicine Centers by Kovalchuk, M V, Sergunova, K A, Vodovatov, A V, Dyakova, Yu A, Zavaleva, E V, Ramazanova, M R, Trashkov, A P, Chipiga, L A, Brinkevich, S D, Rumyantsev, P O

“…Nuclear medicine was developed at the beginning of the 20th century, when John Lawrence first tested therapy with artificially produced radioisotopes in…”
Get full text

Assessment of Inhibition of the Growth of Breast and Colon Tumors when Blocking VEGFR-1 with Monoclonal Antibodies by Shtam, T A, Demyanov, A V, Garaeva, L A, Emelianova, S S, Nikitina, A V, Putevich, E D, Potyseva, A S, Bidghieva, M S, Volnitskiy, A V, Kvanchiani, V V, Solomina, L A, Shabalin, K A, Sergeeva, E V, Trashkov, A P, Yu, Sidorova Zh, Zhahov, A V, Burdakov, V S, Verlov, N A, Konevega, A L

“…Vascular endothelial growth factor receptor-1 (VEGFR-1) plays a critical role in tumor-associated angiogenesis. VEGFR-1 is found on the surface of tumor cells…”
Get full text

Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases by Maystrenko, D N, Stanzhevsky, A A, Sergunova, K A, Shatik, S V, Antuganov, D O, Al, Shehadat R, Sysoev, D S, Nadporozhsky, M S, Konevega, A L, Trashkov, A P, Molchanov, O E, Chipiga, L A, Vodovatov, A V

“…The pharmaceutical development of innovative radiopharmaceuticals (RPs) based on bispecific high-affinity hypervariable fragments of single-domain monoclonal…”
Get full text

Radiopharmaceuticals Based on Ligands to Gastrin-Releasing Peptide Receptors: Current State of the Issue and Russian Developments by Maystrenko, D N, Stanzhevsky, A A, Sergunova, K A, Shatik, S V, Antuganov, D O, Sysoev, D S, Nadporozhsky, M S, Konevega, A L, Trashkov, A P, Molchanov, O E, Maksimov, V I, Chipiga, L A, Vodovatov, A V, Popova, A A

“…Data are presented on ligands based on bombesin derivatives, which are peptides that specifically bind to gastrin-releasing factor receptors, that are…”
Get full text

Signs and Symptoms of Central Nervous System Involvement and Their Pathogenesis in COVID-19 According to The Clinical Data (Review) by Tsygan, N. V., Trashkov, A. P., Ryabtsev, A. V., Yakovleva, V. A., Konevega, A. L., Vasiliev, A. G., Tsygan, V. N., Odinak, M. M., Litvinenko, I. V.

“…Detailed clinical assessment of the central nervous system involvement in SARS-CoV-2 infection is relevant due to the low specificity of neurological…”
Get full text

Metabolic and hormonal indices in rats with a prolonged model of the metabolic syndrome induced by a high-carbohydrate and high-fat diet by Derkach, K. V., Bondareva, V. M., Trashkov, A. P., Chistyakova, O. V., Verlov, N. A., Shpakov, A. O.

“…To develop approaches for the prevention and treatment of the metabolic syndrome (MS), a pathological state widespread in the modern population, that involves…”
Get full text

Metabolic and hormonal indices in rats with prolonged model of metabolic syndrome induced by high-carbohydrate and high-fat diet by Derkach, K V, Bondareva, V M, Trashkov, A P, Chistyakova, O V, Verlov, N A, Shpakov, A O

“…To develop the approaches for the prevention and treatment of metabolic syndrome (MS), a pathological state widespread in modern population, that involves a…”
Get more information

P388 Leukemia in CDF1 Mice as the Test System for Studies of Tumor-Associated Neoangiogenesis and Hypercoagulation by Trashkov, A. P., Panchenko, A. V., Kayukova, E. S., Korablev, R. V., Pechatnikova, V. A., Vasil’ev, A. G., Anisimov, V. N.

“…Blood levels of vascular endothelial growth factor, the main marker of angiogenesis activity, and coagulation hemostasis were studied in CDF 1 mice with…”
Get full text

Characteristics of the regulation of neurotrophic mechanisms in ischemic stroke by Tsygan, N V, Trashkov, A P, Yakovleva, V A, Malkova, V M, Gracheva, E V, Kovalenko, A L, Vasiliev, A G

“…To explore the endogenous and pharmacological activation of neurotrophic mechanisms in a model of brain ischemic lesion in rats. The study was performed on 170…”
Get more information

The Effect of Acute Phase Inflammatory Proteins on the Activity of Peripheral Blood Neutrophils by Fedorova, N. D., Sumbatyan, D. A., Sokolov, A. V., Filatov, M. V., Trashkov, A. P., Varfolomeeva, E. Yu

“…Neutrophils are the leading cells of the innate immune system and the main population of leukocytes responsible for the primary reaction of the body to various…”
Get full text

METABOLIC CORRECTOR WITH HEPATOPROTECTIVE PROPERTIES RUNIHOL®: FROM SCREENING TO CLINICAL TESTING by Stelmakh, V V, Trashkov, A P, Kovalenko, A L, Kozlov, V K, Savateeva-Lyubimova, T N

Get more information

Pathogenic variants of brain injuries and pharmalogic cerebroprotection performed on the model of brain condition during cardiovascular bypass surgery by Tsygan, N V, Trashkov, A P

“…Developed and approved a pathogenic grounded experimental model of brain condition during cardiovascular bypass surgery. Undertaken in Wistar rats research…”
Get more information

Assessment of the therapeutic effect of the drug Molixan in the treatment of Syrian hamsters experimentally infected with the SARS-CoV-2 virus by M. A. Gulyaeva, L. V. Shestopalova, X. Din, A. Yu. Alekseev, A. G. Markhaev, А. Yu. Filippova, V. G. Antonov, A. P. Trashkov, A. M. Shestopalov

“…Background. Studying the characteristics of the course of coronavirus infection caused by SARS-CoV-2 remains relevant due to the high mutagenicity of the virus…”
Get full text

IMMUNE RESISTANCE VIA A PD-1/PD-L1 MECHANISM IN GLIOBLASTOMA by V.S., KUSHNIROVA, S.S., SKLYAR, K.A., SAMOCHERNYKH, A.P., TRASHKOV, B.I., SAFAROV

“…Immunotherapy is a treatment option that is becoming more common for different types of cancer. The idea behind this therapy is to modify the patient's immune…”
Get full text

Brain functional state and cytoprotective potential in model of acute cerebral hypoxia (experimental research) by Tsygan, N V, Trashkov, A P

“…The functional state of the brain and the potential of pharmacologic cytoprotection after an acute cerebral hypoxia were studied. The experiment involved 186…”
Get more information

INFLUENCE OF ANGIOPROTECTOR DRUGS ON THE EFFICACY OF CYTOSTATIC THERAPY (EXPERIMENTAL STUDY) by Trashkov, A P, Vasil'ev, A G, Kovalenko, A L, Petrov, A Yu, Valeev, V V

“…The influence of angioprotector and endothelium-protector drugs pentoxifylline and unifuzol as components of supportive therapy on the efficacy of combined…”
Get more information

Pathophysiological and clinical aspects of using L-arginine in cardiology and angiology by Valeev, V V, Trashkov, A P, Kovalenko, A L, Vasil'ev, A G

“…Presented herein is a review of scientific publications dedicated to studying the pharmacodynamics of L-arginine and possibilities of its clinical application…”
Get more information

Metabolic therapy of nephrolithiasis in two different rat models of kidney disease by Trashkov, A P, Vasiliev, A G, Kovalenko, A L, Tagirov, N S

“…108 albino male rats were used in two experimental rat models reproducing urolithiasis for the assessment of metabolic drug medicine Remaxol nephroprotective…”
Get more information

P388 Leukemia in CDF^sub 1^ Mice as the Test System for Studies of Tumor-Associated Neoangiogenesis and Hypercoagulation by Trashkov, A P, Panchenko, A V, Kayukova, E S, Korablev, R V, Pechatnikova, V A, Vasil'ev, A G, Anisimov, V N

“…Blood levels of vascular endothelial growth factor, the main marker of angiogenesis activity, and coagulation hemostasis were studied in CDF^sub 1^ mice with…”
Get full text